The emerging role of RNA N6-methyladenosine methylation in breast cancer

被引：0
|
作者：
Fangchao Zheng
Feng Du
Jiuda Zhao
Xue Wang
Yiran Si
Peng Jin
Haili Qian
Binghe Xu
Peng Yuan
机构：
[1] Chinese Academy of Medical Sciences and Peking Union Medical College,Department of Medical Oncology, National Cancer Centre/National Clinical Research Center for Cancer/Cancer Hospital
[2] Peking University Cancer Hospital and Institute,Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), The VIPII Gastrointestinal Cancer Division of Medical Department
[3] Affiliated Hospital of Qinghai University & Affiliated Cancer Hospital of Qinghai University,Breast Disease Diagnosis and Treatment Center
[4] Chinese Academy of Medical Sciences and Peking Union Medical College,Department of VIP Medical Services, National Cancer Centre/National Clinical Research Center for Cancer/Cancer Hospital
[5] Chinese Academy of Medical Sciences and Peking Union Medical College,Department of Surgery, National Cancer Centre/National Clinical Research Center for Cancer/Cancer Hospital
[6] Chinese Academy of Medical Sciences and Peking Union Medical College,State Key Laboratory of Molecular Oncology, Cancer Hospital/Institute
来源：
Biomarker Research | / 9卷
关键词：
RNA methylation; Breast cancer; Clinicopathological features; Prognosis; Drug target;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
N6-methyladenosine (m6A) modification is the most prevalent internal mRNA modification and is involved in many biological processes in eukaryotes. Accumulating evidence has demonstrated that m6A may play either a promoting or suppressing role in breast cancer, including in tumorigenesis, metastasis and angiogenesis. In this review, we summarize the latest research progress on the biological function and prognostic value of m6A modification in breast cancer, as well as potential related therapeutic strategies.
引用
收藏
相关论文
共 50 条
  • [21] The potential role of RNA N6-methyladenosine in Cancer progression
    Tianyi Wang
    Shan Kong
    Mei Tao
    Shaoqing Ju
    Molecular Cancer, 19
  • [22] The potential role of RNA N6-methyladenosine in Cancer progression
    Wang, Tianyi
    Kong, Shan
    Tao, Mei
    Ju, Shaoqing
    MOLECULAR CANCER, 2020, 19 (01)
  • [23] Emerging function of N6-methyladenosine in cancer
    Hong, Kwonho
    ONCOLOGY LETTERS, 2018, 16 (05) : 5519 - 5524
  • [24] The essential role of N6-methyladenosine RNA methylation in complex eye diseases
    Li, Xiaohua
    Ma, Binyun
    Zhang, Wenfang
    Song, Zongming
    Zhang, Xiaodan
    Liao, Mengyu
    Li, Xue
    Zhao, Xueru
    Du, Mei
    Yu, Jinguo
    He, Shikun
    Yan, Hua
    GENES & DISEASES, 2023, 10 (02) : 505 - 520
  • [25] Research progress on the role of RNA N6-methyladenosine methylation in HCV infection
    Ge, Yiyang
    Tang, Shi
    Xia, Tian
    Shi, Chunwei
    VIROLOGY, 2023, 582 : 35 - 42
  • [26] N6-methyladenosine RNA methylation regulators contribute to the progression of prostate cancer
    Wu, Qunying
    Xie, Xing
    Huang, Yiming
    Meng, Shanshan
    Li, Youcheng
    Wang, Huifeng
    Hu, Yanling
    JOURNAL OF CANCER, 2021, 12 (03): : 682 - 692
  • [27] Prognostic implications of N6-methyladenosine RNA regulators in breast cancer
    Jiaojiao Tai
    Linbang Wang
    Hao Guo
    Ziqiang Yan
    Jingkun Liu
    Scientific Reports, 12
  • [28] Prognostic implications of N6-methyladenosine RNA regulators in breast cancer
    Tai, Jiaojiao
    Wang, Linbang
    Guo, Hao
    Yan, Ziqiang
    Liu, Jingkun
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [29] Mechanism of N6-methyladenosine modification and its emerging role in cancer
    Zhang, Sicong
    PHARMACOLOGY & THERAPEUTICS, 2018, 189 : 173 - 183
  • [30] N6-methyladenosine RNA methylation in diabetic kidney disease
    Huang, Jiaan
    Yang, Fan
    Liu, Yan
    Wang, Yuehua
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 171
12345